Da-liang Ou

No. 1, Sec. 4, Roosevelt Rd, 106
TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Integration of multi-omics for precision therapy in breast cancer.

Integration of multi-omics for precision therapy in breast cancer.

Journal: Drug discovery today

Published: February 27, 2026

Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration"".

Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration"".

Journal: Journal of hepatology

Published: December 02, 2025

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Journal: Life sciences

Published: August 20, 2025

Local M1 Macrophage Reprogramming with Gluconic Acid-Coated Selenium Nanoparticles.

Local M1 Macrophage Reprogramming with Gluconic Acid-Coated Selenium Nanoparticles.

Journal: International journal of nanomedicine

Published: July 25, 2025

Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Journal: Molecular cancer

Published: June 23, 2025

Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitors.

Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 13, 2025

Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models.

Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models.

Journal: Journal for immunotherapy of cancer

Published: December 19, 2024

Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration.

Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration.

Journal: Journal of hepatology

Published: November 10, 2024

Regorafenib enhances M1/M2 macrophage polarization by inhibiting the secretion of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.

Regorafenib enhances M1/M2 macrophage polarization by inhibiting the secretion of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.

Journal: Life sciences

Published: April 29, 2024

A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies.

A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies.

Journal: Drug discovery today

Published: November 28, 2023

Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer.

Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer.

Journal: Journal of biomedical science

Published: June 23, 2023

Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.

Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.

Journal: Cancer gene therapy

Published: May 25, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026